Results 121 to 130 of about 59,490 (296)
Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome [PDF]
, 2021 Romina S. Álvarez +7 more
openalex +1 more source
Atypical hemolytic uremic syndrome: a syndrome in need of clarity
Clinical Kidney Journal, 2018 Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) originally understood to be limited to renal and hematopoietic involvement.
B. Berger
semanticscholar +1 more source
Eculizumab experience in an adult patient with atypical hemolytic uremic syndrome
Saudi Journal of Kidney Diseases and Transplantation, 2017 Atypical hemolytic-uremic syndrome is a disease characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal failure. In this study, we present a case of a patient with atypical hemolytic-uremic syndrome treated successfully with eculizumab ...
Funda Sari +6 more
doaj +1 more source
Clinical Pharmacology: Advances and Applications, 2011 Maro Ohanian, Christian Cable, Kathleen HalkaDepartment of Hematology and Oncology, Scott and White Healthcare, The Texas A&M Health Science Center College of Medicine, Temple, TX, USAAbstract: This case report describes how eculizumab reversed ...
Ohanian M, Cable CC, Halka KK
doaj
Aktualʹnaâ Infektologiâ, 2016 The article presents information about Escherichia coli infections, the outbreak of which was recorded in 2011 in Europe. In Hrodno region for 15 years of observations, there were registered 158 cases of Escherichia coli infection, the proportion of ...
N.V. Pronko +2 more
doaj +1 more source
Shiga Toxin Detection Methods : A Short Review [PDF]
, 2013 The Shiga toxins comprise a family of related protein toxins secreted by certain types of bacteria. Shigella dysenteriae, some strain of Escherichia coli and other bacterias can express toxins which caused serious complication during the infection. Shiga
González-Aguilar, G. +1 more
core
Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizimab treatment [PDF]
, 2016 Background: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment. We report a post hoc analysis investigating the effect of baseline factors, including patient characteristics and ...
Ardissimo, Gianluigi +5 more
core +2 more sources
RISK OF HEMOLYTIC UREMIC SYNDROME FOLLOWING SPORADIC E. COLI O157 INFECTION: RESULTS OF A CANADIAN COLLABORATIVE STUDY † 760 [PDF]
, 1997 Peter C. Rowe +4 more
openalex +1 more source
Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4 [PDF]
, 2014 Haemolytic uraemic syndrome caused by Shiga toxin-producing E. coli (STEC) is dependent on release of Shiga toxins (Stxs) during intestinal infection and subsequent absorption into the bloodstream.
Billoud, Lucile +4 more
core +2 more sources